The Claim
Antithyroid drug therapy in Graves' disease is associated with a modest increase in absolute regulatory T cell counts, while the percentage of regulatory T cells remains unchanged, indicating partial immune modulation without restoration of regulatory balance.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with Graves' disease, antithyroid drugs increase the total number of regulatory T cells but do not change the proportion of these cells among all T cells.
See the scientific wording
Antithyroid drug therapy in Graves' disease is associated with a modest increase in absolute regulatory T cell counts, though the percentage of Tregs remains unchanged, suggesting partial immune modulation without full restoration of regulatory balance.
When the thyroid produces too much hormone, the immune system becomes overactive and loses some of its calming cells. Medicines that reduce thyroid hormone levels allow these calming cells to return in number, but they still make up the same small fraction of all immune cells because other immune cells also increase. The immune system becomes less aggressive, but it does not fully return to a balanced state.
What the research says
1 studyAfter taking medicine for Graves' disease, the total number of immune cells that calm down the immune system goes up a little, but their share of all immune cells stays about the same — meaning the body is still not fully back to normal.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.